RU2016106583A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016106583A3 RU2016106583A3 RU2016106583A RU2016106583A RU2016106583A3 RU 2016106583 A3 RU2016106583 A3 RU 2016106583A3 RU 2016106583 A RU2016106583 A RU 2016106583A RU 2016106583 A RU2016106583 A RU 2016106583A RU 2016106583 A3 RU2016106583 A3 RU 2016106583A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361862977P | 2013-08-07 | 2013-08-07 | |
| US61/862,977 | 2013-08-07 | ||
| PCT/IB2014/063777 WO2015019318A1 (en) | 2013-08-07 | 2014-08-07 | Peptides capable of reactivating p53 mutants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019119609A Division RU2721423C2 (ru) | 2013-08-07 | 2014-08-07 | Пептиды, способные реактивировать мутанты р53 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016106583A RU2016106583A (ru) | 2017-08-30 |
| RU2016106583A3 true RU2016106583A3 (ru) | 2018-03-29 |
| RU2693487C2 RU2693487C2 (ru) | 2019-07-03 |
Family
ID=52460737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019119609A RU2721423C2 (ru) | 2013-08-07 | 2014-08-07 | Пептиды, способные реактивировать мутанты р53 |
| RU2016106583A RU2693487C2 (ru) | 2013-08-07 | 2014-08-07 | Пептиды, способные реактивировать мутанты р53 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019119609A RU2721423C2 (ru) | 2013-08-07 | 2014-08-07 | Пептиды, способные реактивировать мутанты р53 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9856289B2 (ru) |
| EP (1) | EP3030571B1 (ru) |
| JP (2) | JP6554099B2 (ru) |
| CN (1) | CN105579464B (ru) |
| AU (2) | AU2016200713B2 (ru) |
| BR (1) | BR112016002721A2 (ru) |
| CA (1) | CA2920147C (ru) |
| ES (1) | ES2795982T3 (ru) |
| HK (1) | HK1219742A1 (ru) |
| HU (1) | HUE049292T2 (ru) |
| IL (2) | IL243944B (ru) |
| RU (2) | RU2721423C2 (ru) |
| WO (1) | WO2015019318A1 (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2920147C (en) | 2013-08-07 | 2022-09-20 | Yeda Research And Development Co. Ltd. | Peptides capable of reactivating p53 mutants |
| CN105112377B (zh) * | 2015-09-25 | 2018-10-30 | 福州迈新生物技术开发有限公司 | 一株分泌抗p53单克隆抗体的杂交瘤细胞株及其应用 |
| US20220251159A1 (en) * | 2016-02-04 | 2022-08-11 | Yeda Research And Development Co., Ltd | Peptides and use of same in the treatment of diseases, disroders or conditions associated with a mutant p53 |
| WO2017134671A1 (en) | 2016-02-04 | 2017-08-10 | Yeda Research And Development Co. Ltd. | Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53 |
| US11939365B2 (en) * | 2017-09-29 | 2024-03-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors recognizing mutated P53 |
| KR102546138B1 (ko) | 2017-12-07 | 2023-06-23 | 리벤 아이피 홀드코 엘엘씨 | 대사 상태의 치료를 위한 조성물 및 방법 |
| EP3723785A1 (en) * | 2017-12-17 | 2020-10-21 | Yeda Research and Development Co. Ltd | Cop9 signalosome (csn) complex modulators and uses thereof |
| WO2019134070A1 (en) * | 2018-01-02 | 2019-07-11 | Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine | Panda as novel therapeutic |
| WO2019134650A1 (en) * | 2018-01-02 | 2019-07-11 | Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine | Mp53 rescue compounds and methods of treating a p53 disorder |
| TW202112358A (zh) * | 2019-06-12 | 2021-04-01 | 美商里文Ｉｐ控股有限責任公司 | 用於改善癌症病患之成效的方法及組成物 |
| JP7402026B2 (ja) | 2019-11-27 | 2023-12-20 | 株式会社小松製作所 | 作業機械の制御システム、作業機械、作業機械の制御方法 |
| WO2021186431A1 (en) | 2020-03-16 | 2021-09-23 | Yeda Research And Development Co. Ltd. | Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein |
| CN111574591B (zh) * | 2020-04-29 | 2021-09-21 | 西安交通大学医学院第一附属医院 | 一种多肽及其合成方法 |
| CN111686127B (zh) * | 2020-06-04 | 2022-02-15 | 华南理工大学 | 锌铁纳米材料在降解突变p53蛋白中的应用 |
| CN113750246B (zh) * | 2020-06-04 | 2023-12-05 | 华南理工大学 | ZIF-8纳米材料在降解广谱突变p53蛋白中的应用 |
| US20230049952A1 (en) * | 2020-06-24 | 2023-02-16 | Pmv Pharmaceuticals, Inc. | Methods and compounds for restoring mutant p53 function |
| CN112921032A (zh) * | 2020-12-29 | 2021-06-08 | 苏州中科先进技术研究院有限公司 | 一种引物对、探针、试剂盒及其使用方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
| US5614393A (en) * | 1991-10-10 | 1997-03-25 | Rhone-Poulenc Agrochimie | Production of γ-linolenic acid by a Δ6-desaturase |
| US5969120A (en) * | 1993-09-03 | 1999-10-19 | Research Development Foundation | Mutants of the RB and P53 genes |
| US6184205B1 (en) | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
| US6169073B1 (en) * | 1995-02-16 | 2001-01-02 | Bayer Corporation | Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| US5877282A (en) | 1996-09-20 | 1999-03-02 | Bristol-Myers Squibb Company | Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| AU7238098A (en) * | 1997-05-15 | 1998-12-08 | Kyowa Hakko Kogyo Co. Ltd. | Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants |
| US20030224379A1 (en) * | 2000-01-21 | 2003-12-04 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| EP1377314B1 (en) | 2001-01-26 | 2011-09-14 | Inhibitex, Inc. | Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| US20040214184A1 (en) * | 2001-02-28 | 2004-10-28 | Skubitz Keith M | Small peptides capable of modulating the function of cd66 (ceacam) family members |
| AU2003205830A1 (en) * | 2002-01-23 | 2003-09-02 | Mohamed Raafat El-Gewely | Molecular libraries |
| US7361747B2 (en) * | 2003-05-22 | 2008-04-22 | The University Of Hong Kong | Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus |
| WO2007149062A2 (en) * | 2005-03-14 | 2007-12-27 | Board Of Regents, The University Of Texas System | Bioactive fus1 peptides and nanoprticle-polypeptide complexes |
| WO2009094006A2 (en) * | 2007-10-25 | 2009-07-30 | Wake Forest University Health Sciences | Bordetella outer-membrane protein antigens and methods of making and using the same |
| WO2009112075A1 (en) * | 2008-03-13 | 2009-09-17 | Universita' Degli Studi Di Trieste | Peptides and aptamers thereof as specific modulators of mutant p53 function |
| US8287845B2 (en) * | 2008-12-18 | 2012-10-16 | E I Du Pont De Nemours And Company | Hair-binding peptides |
| EP3444262A3 (en) * | 2011-09-09 | 2019-04-10 | Agency For Science, Technology And Research | P53 activating peptides |
| EP2771349B1 (en) * | 2011-09-16 | 2020-02-26 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| CA2884677C (en) * | 2012-09-13 | 2020-06-23 | Universite De Geneve | Cell penetrating peptides derived from the epstein barr virus, compositions and methods thereof |
| CA2920147C (en) | 2013-08-07 | 2022-09-20 | Yeda Research And Development Co. Ltd. | Peptides capable of reactivating p53 mutants |
| WO2017134671A1 (en) | 2016-02-04 | 2017-08-10 | Yeda Research And Development Co. Ltd. | Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53 |
-
2014
- 2014-08-07 CA CA2920147A patent/CA2920147C/en active Active
- 2014-08-07 ES ES14834903T patent/ES2795982T3/es active Active
- 2014-08-07 EP EP14834903.8A patent/EP3030571B1/en active Active
- 2014-08-07 JP JP2016532782A patent/JP6554099B2/ja active Active
- 2014-08-07 RU RU2019119609A patent/RU2721423C2/ru active
- 2014-08-07 CN CN201480053550.8A patent/CN105579464B/zh active Active
- 2014-08-07 RU RU2016106583A patent/RU2693487C2/ru active
- 2014-08-07 BR BR112016002721-3A patent/BR112016002721A2/pt not_active Application Discontinuation
- 2014-08-07 WO PCT/IB2014/063777 patent/WO2015019318A1/en active Application Filing
- 2014-08-07 HU HUE14834903A patent/HUE049292T2/hu unknown
-
2016
- 2016-02-04 AU AU2016200713A patent/AU2016200713B2/en active Active
- 2016-02-04 US US15/015,208 patent/US9856289B2/en active Active
- 2016-02-04 IL IL243944A patent/IL243944B/en active IP Right Grant
- 2016-07-04 HK HK16107750.7A patent/HK1219742A1/zh unknown
-
2017
- 2017-04-28 AU AU2017202806A patent/AU2017202806B2/en not_active Ceased
- 2017-10-29 US US15/796,811 patent/US10336789B2/en active Active
-
2019
- 2019-06-25 US US16/451,081 patent/US10550152B2/en active Active
- 2019-07-04 JP JP2019125644A patent/JP2019214573A/ja active Pending
- 2019-07-30 IL IL268355A patent/IL268355A/en unknown
- 2019-12-05 US US16/704,010 patent/US11028127B2/en active Active